Pharmaceuticals

The Rising Pharmaceutical Production Fueling The Growth Of The Market Due To Increasing Healthcare Demand Is Supporting Development Across The Pharma Grade Cellulose Powder Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Size Of The Pharma Grade Cellulose Powder Market Progress Through 2030?

The pharma grade cellulose powder market has shown significant growth in recent years. Its size is expected to expand from $1.55 billion in 2025 to $1.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. This historical growth can be linked to factors such as the rise in oral drug formulations, the broad application of cellulose excipients, the expansion within pharmaceutical manufacturing, the demand for formulation stability, and the regulatory acceptance of cellulose-based excipients.

The pharma grade cellulose powder market is anticipated to experience robust expansion over the coming years, with projections indicating an increase to $2.09 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period can be attributed to several factors including an increase in nutraceutical applications, a rising need for clean-label excipients, the expansion of generic drug pipelines, advancements in excipient engineering, and escalating sustainability requirements. Key trends expected in this period encompass a growing demand for plant-based pharmaceutical excipients, increased utilization in solid oral dosage forms, the rising adoption of microcrystalline cellulose, the expansion of multi-functional cellulose excipients, and an intensified focus on sustainable excipient sourcing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24373&type=smp

Which Growth Drivers Are Expected To Support The Pharma Grade Cellulose Powder Market Forward?

The anticipated expansion in pharmaceutical manufacturing is poised to boost the pharma-grade cellulose powder market’s development in the future. This production process encompasses the creation of medications through the formulation, synthesis, and stringent quality control of both active components and excipients, guaranteeing their safety, efficacy, and adherence to regulations. The volume of pharmaceutical output is growing because of the increase in chronic illnesses, which necessitate ongoing and sustained drug regimens for proper management. Pharma-grade cellulose powder aids pharmaceutical manufacturing by serving as a reliable binder, filler, and stabilizer, crucial for preserving tablet structure and ensuring consistent drug dispersion. For example, data from June 2023, provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade organization representing Europe’s pharmaceutical sector, indicates that total pharmaceutical production in Europe reached $422,803 million (€390,000 million) in 2023, an increase from $393,857 million (€363,300 million) in 2022. Consequently, the expanding pharmaceutical production is propelling the advancement of the pharma-grade cellulose powder market.

How Is Segment Classification Applied In The Pharma Grade Cellulose Powder Market?

The pharma grade cellulose powder market covered in this report is segmented –

1) By Product Type: Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Hydroxypropyl Methylcellulose (HPMC), Hydroxypropyl Cellulose (HPC)

2) By Functionality: Binding Agent, Thickening Agent, Stabilizer, Disintegrant, Coating Agent

3) By Application: Pharmaceuticals, Nutraceuticals, Cosmetics, Other Applications

4) By End-User: Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic And Research Institutions, Manufacturers Of Dietary Supplements, Food And Beverage Industries

Subsegments:

1) By Microcrystalline Cellulose: Powder, Granules

2) By Carboxymethyl Cellulose (CMC): Sodium Carboxymethyl Cellulose (CMC), Calcium Carboxymethyl Cellulose (CMC), Other Carboxymethyl Cellulose (CMC) Variants

3) By Hydroxypropyl Methylcellulose (HPMC): Low Viscosity Hydroxypropyl Methylcellulose (HPMC), Medium Viscosity Hydroxypropyl Methylcellulose (HPMC), High Viscosity Hydroxypropyl Methylcellulose (HPMC)

4) By Hydroxypropyl Cellulose: Low Substitution Hydroxypropyl Cellulose (HPC), High Substitution Hydroxypropyl Cellulose (HPC)

What Trends Are Influencing The Pharma Grade Cellulose Powder Market Outlook?

Key companies operating in the pharma-grade cellulose powder market are prioritizing the development of new microcrystalline cellulose facilities to expand their production capacity and reinforce their supply chain capabilities for pharmaceutical excipients. A microcrystalline cellulose facility serves as a specialized plant where purified cellulose undergoes precise chemical and mechanical treatments to generate uniform, fine-grade particles suitable for pharmaceutical applications. For instance, in September 2023, Nitika Pharmaceuticals Specialties, an India-based excipient manufacturing company, launched Tabcell, recognized as India’s largest microcrystalline cellulose (MCC) manufacturing plant, situated in Nagpur. This plant, equipped with cutting-edge technology and boasting an installed capacity of 1200 metric tons, was inaugurated by Union Minister Nitin Gadkari, marking a substantial achievement under the Government of India’s Production Linked Incentive (PLI) scheme for excipients. The establishment of this new plant strengthens Nitika Pharma’s position as a global leader in pharmaceutical excipients, addressing both domestic demands and export requirements for over 92 countries, while also contributing to the “Make in India” initiative and fostering considerable local employment.

Which Organizations Are Involved In The Pharma Grade Cellulose Powder Market?

Major companies operating in the pharma grade cellulose powder market are Roquette Frères, Ashland Global, JRS Pharma, DFE Pharma, Sigachi Industries Ltd., Accent Microcell Ltd., FMC Corporation, Dow Chemical Company, Shin-Etsu Chemical Co. Ltd., Colorcon, Nippon Paper Industries Co. Ltd., Rayonier Advanced Materials, Lotte Fine Chemical, Mingtai Chemical Co. Ltd., Weifang Lude Chemical Co. Ltd., Shandong Head Co. Ltd., Zhejiang Kehong Chemical Co. Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Maple Biotech Pvt. Ltd., Ankit Pulps & Boards Pvt. Ltd.

Access The Complete Pharma Grade Cellulose Powder Market Report:

https://www.thebusinessresearchcompany.com/report/pharma-grade-cellulose-powder-global-market-report

Which Region Is The Dominant Market In The Pharma Grade Cellulose Powder Market?

North America was the largest region in the pharma-grade cellulose powder market in 2025. The regions covered in the pharma grade cellulose powder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pharma Grade Cellulose Powder Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24373&type=smp

Browse Through More Reports Similar to the Global Pharma Grade Cellulose Powder Market 2026, By The Business Research Company

Cellulose Gel Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulose-gel-global-market-report

Cellulose Acetate Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulose-acetate-global-market-report

Cellulose Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulose-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795